clinical trial on medicinal products may be started only after the ethics committee has delivered an opinion in favor of it, and on the condition that the Finnish Medicines Agency has granted it the licence required in the Medicines Act or it has not informed of any obstacle to starting the research as laid down in the Medicines Act.